Bristol-Myers Squibb (BMY) Says EPO Upheld Decision That Found '038 Patent Invalid

February 1, 2017 12:22 PM EST Send to a Friend
Bristol-Myers Squibb Company (NYSE: BMY) announced today that the European Patent Office (EPO) upheld a decision with regard to European ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login